Podcast Episodes
Back to SearchNEJM January 2026 Fremanezumab in Children and Adolescents with Episodic Migraine
This study investigated whether fremanezumab, a treatment already used by adults, could effectively reduce the frequency of episodic migraines in chi…
9 months ago
NEJM January 2026 ORIGINAL ARTICLE Share on Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD
This research study evaluates a groundbreaking subretinal photovoltaic implant designed to combat vision loss caused by geographic atrophy, a severe …
9 months ago
NEJM January 2026;Medical Management and Revascularization for Asymptomatic Carotid Stenosis
This research study evaluates the most effective way to treat patients with severely blocked carotid arteries who have not yet experienced symptoms l…
9 months ago
Lancet : January 2026 Mortality and long-term exposure to source-specific PM2·5: evidence from a national cohort study in China
This research investigates how long-term exposure to fine particulate matter from different origins impacts death rates across mainland China. By tra…
9 months ago
Lancet : January 2026:SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies
This research examined how oral antiviral medications influence the duration of contagiousness and the frequency of viral rebound in patients with CO…
9 months ago
Lancet : January 2026, REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial
This clinical study investigates a pioneering medical treatment called REGENECYTE, which utilizes umbilical cord blood cells to combat the persistent…
9 months ago
NEJM January 8, 2026 RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
This research study evaluates the impact of a specific bivalent vaccine on reducing severe illness from respiratory syncytial virus (RSV) among indiv…
9 months, 1 week ago
NEJM January 8, 2026 Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
This research study evaluates whether daily fish-oil supplements can protect the heart health of patients undergoing long-term hemodialysis, a group …
9 months, 1 week ago
NEJM January 8, 2026
A recent clinical study investigated the effectiveness of evolocumab, a PCSK9 inhibitor, in preventing major cardiovascular events for individuals wh…
9 months, 1 week ago
Circulation:January 6, 2026:Circulation:January 6, 2026 Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation
This research introduces 3DRECON-QT, a sophisticated artificial intelligence system designed to enhance the safety of patients taking specific heart …
9 months, 1 week ago